Cervical histopathology variability among laboratories: A population-based statewide investigation

American Journal of Clinical Pathology

Volumn 139, Issue 3, 2013, Pages 330-335

  Gage, Julia C ^a   Schiffman, Mark ^a   Hunt, William C ^b   Joste, Nancy ^b   Ghosh, Arpita ^a   Wentzensen, Nicolas ^a   Wheeler, Cosette M ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Cervical intraepithelial neoplasia; Histopathology; Reproducibility

Indexed keywords

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; ADULT; HOSPITAL LABORATORY; PATHOLOGY; STANDARD; UTERINE CERVIX TUMOR;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; LABORATORIES, HOSPITAL; PATHOLOGY, CLINICAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84875900884     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPSD3ZXJXP7NNB     Document Type: Article

References (19)

1. McCluggage WG, Bharucha H, Caughley LM, et al. Interobserver variation in the reporting of cervical colposcopic biopsy specimens: Comparison of grading systems. J Clin Pathol. 1996;49:833-835.
2. Malpica A, Matisic JP, Niekirk DV, et al. Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: Qualitative histopathologic analysis and methodologic issues. Gynecol Oncol. 2005;99(suppl 1):S38-S52.
3. Ismail SM, Colclough AB, Dinnen JS, et al. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ. 1989;298:707-710.
4. de Vet HC, Knipschild PG, Schouten HJ, et al. Sources of interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol. 1992;45:785-790.
5. de Vet HC, Knipschild PG, Schouten HJ, et al. Interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol. 1990;43:1395-1398.
6. Creagh T, Bridger JE, Kupek E, et al. Pathologist variation in reporting cervical borderline epithelial abnormalities and cervical intraepithelial neoplasia. J Clin Pathol. 1995;48:59-60.
7. Cocker J, Fox H, Langley FA. Consistency in the histological diagnosis of epithelial abnormalities of the cervix uteri. J Clin Pathol. 1968;21:67-70.
8. Carreon JD, Sherman ME, Guillen D, et al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: Results from a histological review of population-based cervical samples. Int J Gynecol Pathol. 2007;26:441-446.
9. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285:1500-1505.
10. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: A retrospective cohort study. Lancet Oncol. 2008;9:425-434.
11. Kurman R, Ronnett BM, Sherman M, et al. Tumors of the Cervix, Vagina, and Vulva. Washington, DC: American Registry of Pathology; 2011. AFIP Atlas of Tumor Pathology; series 4, vol 13.
12. Blaustein A, Kurman R. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York: Springer; 2002.
13. Crum CP, Nucci MR, Lee KR. Diagnostic Gynecologic and Obstetric Pathology: Expert Consult-Online and Print. 2nd ed. Philadelphia, PA: Saunders; 2011.
14. Tsoumpou I, Arbyn M, Kyrgiou M, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and metaanalysis. Cancer Treat Rev. 2009;35:210-220.
15. Cuschieri K, Wentzensen N. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2008;17:2536-2545.
16. Wheeler CM, Hunt WC, Cuzick J, et al. A population-based study of HPV genotype prevalence in the United States: Baseline measures prior to mass HPV vaccination. Int J Cancer. 2013;132:198-207.
17. Wentzensen N, Schiffman M, Dunn T, et al. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009;125:2151-2158.
18. Darragh TM, Colgan TJ, Cox JT, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012;16:205-242.
19. Castle PE, Gage JC, Wheeler CM, et al. The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy. Obstet Gynecol. 2011;118:1222-1229.